Center for Substance Abuse Prevention; Notice of Meeting, 48169 [05-16165]
Download as PDF
<![CDATA[
48169
Federal Register / Vol. 70, No. 157 / Tuesday, August 16, 2005 / Notices
facilities serving adults and those
serving children and/or adolescents,
with various subgroups such as forensic
and sexual offender populations.
With input from multiple experts in
the field of restraint and seclusion and
alternatives to restraint and seclusion,
the project created a common core of
data collection instruments that will be
used for this cross-site project. The
facilities will complete four different
instruments: (1) Facility/Program
Characteristics Inventory (information
about type of facilities, characteristics of
persons served, staffing patterns, and
unit specific data); (2) Inventory of
Seclusion and Restraint Reduction
Interventions; (3) Treatment Episode
Data (admission data for all clients/
patients); and (4) Event Data (data about
the use of restraint and seclusion). Data
will be submitted by the sites
electronically via a secured Web site.
The Facility/Program Characteristic
Inventory and Inventory of Seclusion
and Restraint Reduction Intervention
will be collected annually. The
Treatment Episode Data and Event Data
will be collected monthly.
The resulting data will help to
identify the: (1) Number of programs
adopting best practices involving
alternative approaches to restraint and
seclusion; and (2) program’s impact of
reducing restraint and seclusion use and
adoption of alternative practices. The
estimated annual response burden to
collect this information is as follows:
Number of
respondents
Instrument
Responses/
respondent
Burden/
response
(hours)
Annual burden
(hours)
Facility/Program Characteristic Inventory ........................................................
Inventory of Seclusion and Restraint Reduction Interventions .......................
Treatment Episode Data ..................................................................................
Event Data .......................................................................................................
49
49
49
49
1
1
12
12
4
2
8
8
196
98
4,704
4,704
Total ..........................................................................................................
49
........................
........................
9,702
Written comments and
recommendations concerning the
proposed information collection should
be sent by September 15, 2005 to:
SAMHSA Desk Officer, Human
Resources and Housing Branch, Office
of Management and Budget, New
Executive Office Building, Room 10235,
Washington, DC 20503; due to potential
delays in OMB’s receipt and processing
of mail sent through the U.S. Postal
Service, respondents are encouraged to
submit comments by fax to: 202–395–
6974.
Dated: August 9, 2005.
Anna Marsh,
Executive Officer, SAMHSA.
[FR Doc. 05–16179 Filed 8–15–05; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Prevention; Notice of Meeting
Pursuant to Pub. L. 92–463, notice is
hereby given of the meeting of the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
Drug Testing Advisory Board on
September 7–8, 2005.
A portion of the meeting will be open
and will include a roll call, general
announcements, a Department of Health
and Human Services drug testing
program update, a Department of
Transportation drug testing program
update, and a Nuclear Regulatory
VerDate jul<14>2003
18:02 Aug 15, 2005
Jkt 205001
Commission drug testing program
update.
Attendance by the public will be
limited to space available. Public
comments are welcome. Please
communicate with the individual listed
below as contact to make arrangements
to comment or to request special
accommodations for persons with
disabilities.
The Board will also meet to develop
the analytical and administrative
policies for the final revisions to the
Mandatory Guidelines for Federal
Workplace Drug Testing Program that
were published as proposed revisions in
the Federal Register on April 13, 2004
(69 FR 19673). The submissions from
285 commenters have been made
available to the public on the Web site
https://workplace.samhsa.gov. This
meeting will be conducted in closed
session since discussing such public
comments in open session and then
developing the policies will
significantly frustrate the Department’s
ability to develop the final notice of
revisions to the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs. The HHS Office of General
Counsel made the determination that
such matters are protected by exemption
9(B) of section 552b(c) of title 5 U.S.C.
and therefore may be closed to the
public.
Substantive program information and
a roster of Board members may be
obtained by accessing the SAMHSA
workplace Web site (https://
workplace.samhsa.gov) or
communicating with the contact whose
name and telephone number are listed
below. The transcript for the open
session will be available on the
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
SAMHSA workplace Web site as soon as
possible after the meeting.
Committee Name: Substance Abuse and
Mental Health Services Administration Drug
Testing Advisory Board.
Meeting Date: September 7–8, 2005.
Place: Residence Inn by Marriott, 7335
Wisconsin Avenue, Bethesda, Maryland
20814.
Type: Open: September 7, 2005; 8:30 a.m.–
9:30 a.m.
Closed: September 7, 2005; 9:30 a.m.–4:30
p.m.
Closed: September 8, 2005; 8:30 a.m.–
Noon.
Contact: Donna M. Bush, Ph.D., Executive
Secretary, 1 Choke Cherry Road, Room 2–
1033, Rockville, Maryland 20857, 240–276–
2600 (telephone) and 240–276–2610 (fax), email: Donna.Bush@samhsa.hhs.gov.
Dated: August 9, 2005.
Toian Vaughn,
Committee Management Officer, Substance
Abuse and Mental Health Services
Administration.
[FR Doc. 05–16165 Filed 8–15–05; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Treatment; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given of a
Teleconference Meeting of the Center
for Substance Abuse Treatment (CSAT)
National Advisory Council to be held in
September 2005.
The meeting will include the review,
discussion and evaluation of grant
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 70, Number 157 (Tuesday, August 16, 2005)]
[Notices]
[Page 48169]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16165]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Prevention; Notice of Meeting
Pursuant to Pub. L. 92-463, notice is hereby given of the meeting
of the Substance Abuse and Mental Health Services Administration
(SAMHSA) Drug Testing Advisory Board on September 7-8, 2005.
A portion of the meeting will be open and will include a roll call,
general announcements, a Department of Health and Human Services drug
testing program update, a Department of Transportation drug testing
program update, and a Nuclear Regulatory Commission drug testing
program update.
Attendance by the public will be limited to space available. Public
comments are welcome. Please communicate with the individual listed
below as contact to make arrangements to comment or to request special
accommodations for persons with disabilities.
The Board will also meet to develop the analytical and
administrative policies for the final revisions to the Mandatory
Guidelines for Federal Workplace Drug Testing Program that were
published as proposed revisions in the Federal Register on April 13,
2004 (69 FR 19673). The submissions from 285 commenters have been made
available to the public on the Web site https://workplace.samhsa.gov.
This meeting will be conducted in closed session since discussing such
public comments in open session and then developing the policies will
significantly frustrate the Department's ability to develop the final
notice of revisions to the Mandatory Guidelines for Federal Workplace
Drug Testing Programs. The HHS Office of General Counsel made the
determination that such matters are protected by exemption 9(B) of
section 552b(c) of title 5 U.S.C. and therefore may be closed to the
public.
Substantive program information and a roster of Board members may
be obtained by accessing the SAMHSA workplace Web site (https://
workplace.samhsa.gov) or communicating with the contact whose name and
telephone number are listed below. The transcript for the open session
will be available on the SAMHSA workplace Web site as soon as possible
after the meeting.
Committee Name: Substance Abuse and Mental Health Services
Administration Drug Testing Advisory Board.
Meeting Date: September 7-8, 2005.
Place: Residence Inn by Marriott, 7335 Wisconsin Avenue,
Bethesda, Maryland 20814.
Type: Open: September 7, 2005; 8:30 a.m.-9:30 a.m.
Closed: September 7, 2005; 9:30 a.m.-4:30 p.m.
Closed: September 8, 2005; 8:30 a.m.-Noon.
Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke
Cherry Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600
(telephone) and 240-276-2610 (fax), e-mail:
Donna.Bush@samhsa.hhs.gov.
Dated: August 9, 2005.
Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health
Services Administration.
[FR Doc. 05-16165 Filed 8-15-05; 8:45 am]
BILLING CODE 4162-20-P
